Catalyst Wire Dossier Catalyst Wire Dossier

XIENCE V Everolimus-Eluting Coronary Stent System (EECSS)

everolimus-eluting coronary stent · Abbott Vascular
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XIENCE V Everolimus-Eluting Coronary Stent System (EECSS), covering 2016-08-24 to 2019-03-01. Get the full timeline:

Most recent: Clinical Trial Update: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study

See pricing